- Home
- IMVT vs SYNA Comparison
IMVT vs SYNA Comparison
Compare IMVT & SYNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- SYNA
- Stock Information
- Founded
- IMVT 2018
- SYNA 1986
- Country
- IMVT United States
- SYNA United States
- Employees
- IMVT N/A
- SYNA N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- SYNA Computer peripheral equipment
- Sector
- IMVT Health Care
- SYNA Technology
- Exchange
- IMVT Nasdaq
- SYNA Nasdaq
- Market Cap
- IMVT 2.7B
- SYNA 2.7B
- IPO Year
- IMVT N/A
- SYNA 2002
- Fundamental
- Price
- IMVT $15.53
- SYNA $70.51
- Analyst Decision
- IMVT Buy
- SYNA Strong Buy
- Analyst Count
- IMVT 11
- SYNA 7
- Target Price
- IMVT $33.88
- SYNA $92.17
- AVG Volume (30 Days)
- IMVT 1.6M
- SYNA 370.1K
- Earning Date
- IMVT 11-06-2025
- SYNA 11-06-2025
- Dividend Yield
- IMVT N/A
- SYNA N/A
- EPS Growth
- IMVT N/A
- SYNA N/A
- EPS
- IMVT N/A
- SYNA N/A
- Revenue
- IMVT N/A
- SYNA $1,074,300,000.00
- Revenue This Year
- IMVT N/A
- SYNA $10.77
- Revenue Next Year
- IMVT N/A
- SYNA $9.16
- P/E Ratio
- IMVT N/A
- SYNA N/A
- Revenue Growth
- IMVT N/A
- SYNA 11.98
- 52 Week Low
- IMVT $12.72
- SYNA $41.80
- 52 Week High
- IMVT $32.10
- SYNA $89.81
- Technical
- Relative Strength Index (RSI)
- IMVT 46.91
- SYNA 55.69
- Support Level
- IMVT $16.08
- SYNA $68.65
- Resistance Level
- IMVT $17.20
- SYNA $72.04
- Average True Range (ATR)
- IMVT 0.79
- SYNA 1.72
- MACD
- IMVT 0.09
- SYNA -0.03
- Stochastic Oscillator
- IMVT 36.81
- SYNA 72.23
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About SYNA Synaptics Incorporated $0.001 Par Value
Synaptics Inc is a producer of semiconductor solutions for the mobile, PC, and Internet of Things markets. The company develops human interface solutions that enable touch, display, fingerprint, video, audio, voice, AI, and connectivity functions for smartphones, PCs, Internet of Things products, and other electronic devices. It operates in one segment: the development, marketing, and sale of semiconductor products used in electronic devices and products. The company geographically, it derives a majority of revenue from China, and also has its presence in Taiwan, Japan, South Korea, United States and Other countries.